The Influence of Prednisone on the Efficacy of Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer

BACKGROUND: Prednisone and other corticosteroids can provide palliation and tumor responses in patients with prostate cancer. The combination of docetaxel and prednisone was the first treatment shown to prolong survival in men with metastatic castration-resistant prostate cancer (mCRPC). Since the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Teply, Benjamin A., Luber, Brandon, Denmeade, Samuel R., Antonarakis, Emmanuel S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748735/
https://www.ncbi.nlm.nih.gov/pubmed/26857146
http://dx.doi.org/10.1038/pcan.2015.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748735/
https://www.ncbi.nlm.nih.gov/pubmed/26857146
http://dx.doi.org/10.1038/pcan.2015.53

Ejemplares similares